002AN Masas
002AN Masas
002AN Masas
ae
Letters in Organic Chemistry, 2015, 12, 447-458 447
a
Department of Dyestuff Technology, Institute of Chemical Technology, Mumbai 400019, India;
b
National Taiwan University, Taipei 10617, Taiwan; cNational Centre for Nanosciences and
Nanotechnology, University of Mumbai, Mumbai-400098
Received May 12, 2014: Revised October 20, 2014: Accepted April 24, 2015
Abstract: A tandem metal-free synthesis of partly and fully substituted pyrimidines has been
accomplished from ,-unsaturated ketones and benzamidine in presence of triethyl amine. The
reaction proceeds via [3+3] annulation-oxidation sequence and the protocol has been found successful
for the synthesis of a wide range of pyrimidine derivatives.
Keywords: Benzamidine, Metal-free synthesis, Triethyl amine, Tandem [3+3] annulation-oxidation pathway, ,-Unsaturated
ketones.
Previous work: R1
OH NH Cu(II)/ Mn(IV)
N
R1 H2N Ph 120-150 oC
R2 N Ph
R2
R1
NbCl5 R2
R1 N
Ph N
120-150 oC
R2 Ph N Ph
Present work: R1
O NH R2
R2 TEA/CH3CN N
R1 H2N Ph 80 oC
R3 N Ph
R3
O NH
Catalyst, Base N
H2N N
O2 (1.0 atm.),
5h
1a 2 3a
and 3). Considering this relation between temperature and We next investigated the scope and limitations of this re-
yield, we carried out the reaction at 80 °C in acetonitrile and action by using different ,-unsaturated ketones (Table 2).
obtained 48% yield (Table 1, entry 4). When the same reac- ,-Unsaturated ketone 1b bearing no substituent on the
tion was conducted under nitrogen atmosphere a lower yield styryl portion afforded pyrimidine 3b in 75% yield. Chal-
(37%) was obtained (Table 1, entry 5) indicating that the cones (1c-1o) bearing a halogen group on the styryl portion
aromatization proceeded in the presence of atmospheric oxy- produced pyrimidine derivatives (3c-3o) respectively in good
gen. When Cu(OAc)2 was used as the catalyst (Table 1, en- to excellent yield (75-90%, Table 2, entries 3-15). Steric
tries 6 and 7), the reaction failed at room temperature but hindrance due to a halogen group near the double bond of
gave better yield at 80 °C. Similarly, the reaction also failed unsaturated ketones (1d, 1i, 1m) hampered the reaction and
in the absence of metal catalyst at room temperature (Table afforded low yields. We attempted the synthesis of tetrasub-
1, entry 8). To our surprise, 72% yield of the product was stituted pyrimidine (3p) from 3-acetyl coumarin (1p) under
obtained with 1.5 equiv. of triethyl amine in the absence of similar reaction conditions and observed that the reaction
metal catalyst (Table 1, entry 9). The use of 2.0 equiv. of took slightly longer time (8 h) and gave relatively low yield
triethyl amine was found to give the best yield (Table 1, en- (68%). The extended conjugation in -ionone adversely in-
try 10). When other bases such as Na2CO3, Cs2CO3 and DBU fluenced the reaction rate (14 h) and resulted in the forma-
were used, the yields obtained were lower (Table 1, entries tion of 3q in 52% yield. (E)-Pent-3-en-2-one (1r) and (E)-5-
12-14). The choice of solvent was found to be a key factor methylhex-3-en-2-one (1s) also underwent the annulation
(Table 1, entries 15-18). The best result was obtained in ace- reaction and afforded the corresponding pyrimidines (3r and
tonitrile. The reaction did not proceed in the absence of a 3s) in 55 and 63% yields, respectively.
base (Table 1, entry 19).
1 N 5 80
N
1a
3a
CH3
2 6 75
N
CH3
1b N
3b
3 N 4 84
F
N
1c
F
3c
450 Letters in Organic Chemistry, 2015, Vol. 12, No. 7 Vadagaonkar et al.
Table 2. contd….
N
4 5 78
Cl N
1d Cl
3d
N
5 5 85
Cl
N
1e
Cl
3e
N
6 4.5 86
Br
N
1f
Br
3f
Cl
7 N 5 87
N
1g Cl
3g
Cl
8 N 4 88
F
N
1h Cl
F
3h
Metal free Synthesis of 2,4,6-Trisubstituted Pyrimidines Letters in Organic Chemistry, 2015, Vol. 12, No. 7 451
Table 2. contd….
Cl
N
9 4.5 77
Cl N
1i Cl
Cl
3i
Cl
10 N 4 89
Cl
N
1j Cl
Cl
3j
Cl
11 N 4 90
Br
N
1k Cl
Br
3k
CH3
12 4.5 78
N
F CH3
1l N
F
3l
CH3
13 N 5 75
Cl CH3
N
1m
Cl
3m
452 Letters in Organic Chemistry, 2015, Vol. 12, No. 7 Vadagaonkar et al.
Table 2. contd….
CH3
14 4.5 79
N
Cl CH3
1n N
Cl
3n
CH3
15 4.5 80
N
Br CH3
1o N
Br
3o
CH3
N N
16 8 68
O O
CH3
1p
O O
3p
H3C CH3 O
CH3 CH3 N N
17 H3C 14 52
CH3
CH3
1q CH3
3q
CH3
O
N
CH3
18 9 55
H3C N
H3C
1r
3r
Metal free Synthesis of 2,4,6-Trisubstituted Pyrimidines Letters in Organic Chemistry, 2015, Vol. 12, No. 7 453
Table 2. contd….
O CH3
CH3 N
19 H3C H3C 10 63
N
CH3 CH3
1s 3s
a
Reaction conditions: chalcone (1.0 mmol), benzamidine (1.0 mmol), triethylamine (2.0 mmol), CH3CN (10 mL), 80 °C. bIsolated yields.
O R1
NH
R2 R2
R1 TEA (2.0 equiv.) N
H2N Ph
CH3CN, O2 (1 atm.), 80 oC
R3 1 2 R3 N Ph
H+
O
R2
R1
NH
O2
R3 NH
Ph
A
Protonation
HO R1 R1
O O
R2 H R2
R2 N N
R1 R1 NH2 R2 Base
NH -H2O
R1 N Ph R3 N Ph
R3 NH R3 N H H
Ph
Ph
B B' C D
= 109.92, 115.97, 116.18, 125.40, 127.47, 128.53, 128.59, 132.50, 134.52, 137.73, 138.12, 141.37, 163.90, 164.61;
129.37, 129.46, 130.25, 130.86, 130.97, 133.44, 135.18, HRMS (ESI-MS): m/z [M + H]+ calcd for C23H18ClN2:
137.79, 139.30, 163.47, 163.97, 164.69, 166.01; HRMS 357.1158; found: 357.1152.
(ESI-MS): m/z [M + H]+ calcd for C22H15ClFN2: 361.0908;
found: 361.0917. 4-(4-Chlorophenyl)-2-phenyl-6-(p-tolyl)pyrimidine (3n)
White solid; yield 1.50 g; mp 166-168 °C; 1H NMR (400
4-(2-Chlorophenyl)-6-(3-chlorophenyl)-2-phenylpyrimidine MHz, CDCl3): = 2.46 (s, 3H), 7.36 (d, J = 8.0 Hz, 2H),
(3i) 7.53 (m, 5H), 7.93 (s, 1H), 8.20 (dd, J = 8.4, 8.0 Hz, 4H),
White solid; yield 1.46 g; mp 142-144 °C; 1H NMR (400 8.70 (d, J = 6.0 Hz, 2H); 13C NMR (100 MHz, CDCl3): =
MHz, CDCl3): = 7.44-7.54 (m, 8H), 7.85 (t, J = 6.0, 2.4 21.58, 109.66, 127.25, 128.51, 128.53, 128.61, 129.18,
Hz, 1H), 7.99 (s, 1H), 8.12 (d, J = 6.8 Hz, 1H), 8.29 (s, 1H), 129.74, 130.76, 134.58, 136.10, 136.94, 138.12, 141.38,
8.66 (d, J = 4.0 Hz, 2H); 13C NMR (100 MHz, CDCl3): = 163.40, 164.54, 164.92; HRMS (ESI-MS): m/z [M + H] +
115.26, 125.50, 127.36, 127.58, 128.56, 128.62, 130.27, calcd for C23H18ClN2: 357.1158; found: 357.1159.
130.61, 130.91, 130.97, 131.77, 132.48, 135.22, 137.38,
137.72, 139.16, 162.52, 164.83, 165.09; HRMS (ESI-MS): 4-(4-Bromophenyl)-2-phenyl-6-(p-tolyl)pyrimidine (3o)
m/z [M + H]+ calcd for C22H15Cl2N2: 377.0612; found: White solid; yield 1.52 g; mp 174-176 °C; 1H NMR (400
377.0621. MHz, CDCl3): = 2.46 (s, 3H), 7.36 (d, J = 8.0 Hz, 2H),
7.54 (m, 3H), 7.68 (d, J = 8.4 Hz, 2H), 7.93 (s, 1H), 8.17 (m,
4-(3-Chlorophenyl)-6-(4-chlorophenyl)-2-phenylpyrimidine 4H), 8.70 (t, J = 5.6, 2.0 Hz, 2H); 13C NMR (100 MHz,
(3j) CDCl3): = 21.59, 109.62, 125.38, 127.25, 128.52, 128.84,
White solid; yield 1.69 g; mp 140-142 °C; 1H NMR (400 129.74, 130.77, 132.14, 134.56, 136.56, 138.10, 141.39,
163.46, 164.55, 164.94; HRMS (ESI-MS): m/z [M + H] +
MHz, CDCl3): = 7.50-7.53 (m, 7H), 7.87 (s, 1H), 8.10-8.24
calcd for C23H18BrN2: 401.0653; found: 401.0652.
(m, 4H), 8.67 (s, 2H); 13C NMR (100 MHz, CDCl3): =
109.93, 125.39, 127.45, 128.53, 128.61, 129.24, 130.23,
4-Methyl-2-phenyl-5H-chromeno[4,3-d]pyrimidin-5-one
130.90, 131.01, 135.18, 135.67, 137.25, 137.71, 139.18, (3p)
163.51, 163.79, 164.69; HRMS (ESI-MS): m/z [M + H] +
calcd for C22H15Cl2N2: 377.0612; found: 377.0623. Yellow solid; yield 1.27 g; mp 254-256 °C; 1H NMR
(300 MHz, DMSO-d6): = 2.30 (s, 3H), 6.67 (t, J = 7.2 Hz,
4-(4-Bromophenyl)-6-(3-chlorophenyl)-2-phenylpyrimidine 1H), 6.80 (d, J = 7.8 Hz, 1H), 6.91-7.03 (m, 2H), 7.49-7.59
(3k) (m, 3H), 8.08 (d, J = 6.9 Hz, 2H); 13C NMR (75 MHz,
DMSO-d6): = 24.73, 115.34, 119.09, 120.72, 125.44,
White solid; yield 1.72 g; mp 130-132 °C; 1H NMR (400 127.08, 127.64, 128.66, 128.82, 131.44, 132.41, 153.88,
MHz, CDCl3): = 7.49-7.55 (m, 5H), 7.68 (d, J = 8.4 Hz, 155.14, 164.18; HRMS (ESI-MS): m/z [M + H]+ calcd for
2H), 7.91 (s, 1H), 8.12-8.16 (m, 3H), 8.26 (s, 1H), 8.68 (t, J C18H13N2O2: 289.0977; found: 289.0991.
= 4.4, 3.2 Hz, 2H); 13C NMR (100 MHz, CDCl3): =
109.97, 125.41, 125.72, 127.48, 128.54, 128.61, 128.86, 4-Methyl-2-phenyl-6-(2,6,6-trimethylcyclohex-1-en-1-
130.26, 130.92, 131.03, 132.24, 135.20, 136.17, 137.71, yl)pyrimidine (3q)
139.21, 163.62, 163.94, 164.77; HRMS (ESI-MS): m/z [M +
White solid; yield 0.97 g; mp 74-76 °C; 1H NMR (300
H]+ calcd for C22H15BrClN2: 421.0107; found: 421.0104. MHz, CDCl3): = 1.08 (s, 6H), 1.43 (s, 3H), 1.57-1.61 (m,
2H), 1.74-1.83 (m, 2H), 2.09 (t, J = 6.6 Hz, 2H), 2.58 (s,
4-(4-Fluorophenyl)-2-phenyl-6-(p-tolyl)pyrimidine (3l) 3H), 6.83 (d, J = 0.3 Hz, 1H), 7.44-7.49 (m, 3H), 8.44-8.50
White solid; yield 1.47 g; mp 150-152 °C; 1H NMR (400 (m, 2H); 13C NMR (75 MHz, CDCl3): = 19.27, 21.29,
MHz, CDCl3): = 2.46 (s, 3H), 7.24 (distorted t, J = 8.4 Hz, 24.45, 28.93, 32.00, 34.41, 39.47, 120.18, 128.47, 128.49,
2H), 7.36 (d, J = 7.6 Hz, 2H), 7.54 (m, 3H), 7.92 (s, 1H), 128.75, 129.00, 130.30, 131.21, 138.50, 139.28, 163.98,
8.19 (d, J = 7.6 Hz, 2H), 8.27-8.31 (distorted q, J = 6.0, 1.6 166.10, 168.79; HRMS (ESI-MS): m/z [M + H]+ calcd for
Hz, 2H), 8.71 (d, J = 6.0 Hz, 2H); 13C NMR (100 MHz, C20H25N2: 293.2017; found: 293.2068.
CDCl3): = 21.57, 109.58, 115.86, 116.08, 127.24, 128.51,
129.30, 129.39, 129.73, 130.72, 133.79, 134.65, 138.18, 4,6-Dimethyl-2-phenylpyrimidine (3r) [27f]
141.32, 163.37, 163.53, 164.48, 164.81, 165.86; HRMS White solid; yield 0.99 g; mp 82-84 °C; 1H NMR (400
(ESI-MS): m/z [M + H]+ calcd for C23H18FN2: 341.1454; MHz, CDCl3): = 2.51 (s, 6H), 6.89 (s, 1H), 7.42-7.47
found: 341.1458. (m, 3H), 8.40-8.43 (m, 2H); 13C NMR (100 MHz, CDCl3):
= 24.06, 117.85, 128.12, 128.34, 130.16, 138.05, 164.08,
4-(2-Chlorophenyl)-2-phenyl-6-(p-tolyl)pyrimidine (3m) 166.64; HRMS (ESI-MS): m/z [M + H]+ calcd for C12H13N2:
185.1079; found: 185.1093.
White solid; yield 1.42 g; mp 124-126 °C; 1H NMR (400
MHz, CDCl3): = 2.46 (s, 3H), 7.36 (d, J = 7.6 Hz, 2H),
4-Isopropyl-6-methyl-2-phenylpyrimidine (3s)
7.43-7.56 (m, 6H), 7.85 (t, J = 6.8, 2.0 Hz, 1H), 7.99 (s, 1H),
8.19 (d, J = 8.0 Hz, 2H), 8.68 (t, J = 5.2, 1.6 Hz, 2H); 13C White solid; yield 1.15 g; mp 102-104 °C; 1H NMR (400
NMR (100 MHz, CDCl3): = 21.59, 114.89, 127.29, MHz, CDCl3): = 1.33 (d, J = 6.8 Hz, 6H), 2.54 (s, 3H),
127.36, 128.53, 129.76, 130.56, 130.68, 130.71, 131.76, 2.96-3.03 (m, 1H), 6.90 (s, 1H), 7.45 (m, 3H), 8.46 (d, J =
456 Letters in Organic Chemistry, 2015, Vol. 12, No. 7 Vadagaonkar et al.
7.2 Hz, 2H); 13C NMR (100 MHz, CDCl3): = 21.73, 24.26, falciparum dihydrofolate reductase and their antimalarial activities.
35.82, 115.22, 128.16, 128.28, 130.07, 138.29, 163.79, J. Med. Chem., 2004, 47, 673-680.
[3] (a) Waterson, A. G.; Stevens, K. L.; Reno, M. J.; Zhang, Y.-M.;
166.82, 175.22; HRMS (ESI-MS): m/z [M + H]+ calcd for Boros, E. E.; Bouvier, F.; Rastagar, A.; Uehling, D. E.; Dickerson,
C14H17N2: 213.1392; found: 213.1398. S. H.; Reep, B.; McDonald, O. B.; Wood, E. R.; Rusnak, D. W.;
Alligood, K. J.; Rudolph, S. K. Alkynyl pyrimidines as dual
EGFR/ErbB2 kinase inhibitors. Bioorg. Med. Chem. Lett., 2006,
CONCLUSION 16, 2419-2422. (b) Atwal, K. S.; O’Neil, S. V.; Ahmad, S.;
Doweyko, L.; Kirby, M.; Dorso, C. R.; Chandrasena, G.; Chen,
We have developed a tandem metal-free synthesis of B.-C.; Zhao, R.; Zahler, R. Synthesis and biological activity of
pyrimidine derivatives from easily available chalcones and 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine
benzamidine. The protocol is simple, facile and practical. analogs as potent, highly selective, and orally bioavailable NHE-1
inhibitors. Bioorg. Med. Chem. Lett., 2006, 16, 4796-4799. (c)
Further use of these substituted pyrimidines in the synthesis Alvarado, M.; Barceló, M.; Carro, L.; Masaguer, C. F.; Raviña, E.
of D-A type molecules for optoelectronic applications is cur- Synthesis and biological evaluation of new quinazoline and
rently underway in our laboratory. cinnoline derivatives as potential atypical antipsychotics. Chem.
Biodivers., 2006, 3, 106-117. (d) Buurman, E. T.; Blodgett, A. E.;
Hull, K. G.; Carcanague, D. Pyridines and Pyrimidines mediating
CONFLICT OF INTEREST activity against an efflux-negative strain of Candida albicans
through putative inhibition of Lanosterol Demethylase. Antimicrob.
The authors confirm that this article content has no con- Agents Chemother., 2004, 48, 313-318.
flict of interest. [4] (a) Todd, A. R.; Bergel, F. 73. Aneurin. Part VII. A synthesis of
aneurin. J. Chem. Soc., 1937, 364-367. (b) Cline, J. K.; Williams,
R. R.; Finkelstein, J. Studies of crystalline Vitamin B1 . XVII.
Synthesis of Vitamin B1. J. Am. Chem. Soc., 1937, 59, 1052-1054.
ACKNOWLEDGEMENTS (c) Williams, R. R.; Cline, J. K. Synthesis of Vitamin B1. J. Am.
Chem. Soc., 1936, 58, 1504-1505.
This work was supported by CSIR-New Delhi (pool [5] Lin, Y. L.; Huang, R. L.; Chang, C. M.; Kuo, Y. H. Two new
scheme no. 8644-A, sanction no. 01(2427)/10/EMR-II dated puriniums and three new pyrimidines from Heterostemma brownii.
28/12/2010). K.S.V. and H.P.K thank UGC-SAP and CSIR- J. Nat. Prod., 1997, 60, 982-985.
New Delhi, respectively for award of Senior Research Fel- [6] Nagourney, R. A.; Fox, P.; Schein, P. S. A comparison of the
lowships. The authors thank Prof. P. M. Bhate for help in biological and biochemical properties of 1-(4-Amino-2-
methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea and
preparing the manuscript. 2-[3-(2-Chloroethyl)-3-nitrosoureido]-D-glucopyranose. Cancer
Res., 1978, 38, 65-68.
[7] Russell, P. B.; Hitchings, G. H. 2,4-Diaminopyrimidines as
SUPPLEMENTARY MATERIAL antimalarials. III. 5-Aryl derivatives. J. Am. Chem. Soc., 1951, 73,
3763-3770.
Supplementary material is available on the publishers [8] Large, J. M.; Torr, J. E.; Raynaud, F. I.; Clarke, P. A.; Hayes, A.; di
Web site along with the published article. Stefano, F.; Urban, F.; Shuttleworth, S. J.; Saghir, N.; Sheldrake,
P.; Workman, P.; McDonald, E. Preparation and evaluation of
trisubstituted pyrimidines as phosphatidylinositol 3-kinase
REFERENCES inhibitors. 3-Hydroxyphenol analogues and bioisosteric
replacements. Bioorg. Med. Chem., 2011, 19, 836-851.
[1] For selected recent reviews, see: (a) Walker, S. R.; Carter, E. J.; [9] (a) Gompper, R.; Mair, H.-J.; Polborn, K. Synthesis of
Huff, B. C.; Morris, J. C. Variolins and related alkaloids. Chem. oligo(diazaphenyls). Tailor-made fluorescent heteroaromatics and
Rev., 2009, 109, 3080-3098. (b) Dolle, R. E.; Le Bourdonnec, B.; pathways to nanostructures. Synthesis, 1997, 696-718. (b) Kanbara,
Goodman, A. J.; Morales, G. A.; Thomas, C. J.; Zhang, W. T.; Kushida, T.; Saito, N.; Kuwajima, I.; Kubota, K.; Yamamoto,
Comprehensive survey of chemical libraries for drug discovery and T. Preparation and properties of highly electron-accepting
chemical biology: 2008. J. Comb. Chem., 2009, 11, 739-790. (c) Poly(pyrimidine-2,5-diyl). Chem. Lett., 1992, 21, 583-586. (c)
Petricci, E.; Mugnaini, C.; Radi, M.; Togninelli, A.; Bernardini, C.; Hanan, G. S.; Volkmer, D.; Schubert, U. S.; Lehn, J.-M.; Baum, G.;
Manetti, F.; Parlato, M. C.; Renzulli, M. L.; Alongi, M.; Falciani, Fenske, D. Coordination arrays: tetranuclear cobalt(II) complexes
C.; Corelli, F.; Botta, M. Towards new methodologies for the with [22]-Grid Structure. Angew. Chem. Int. Ed., 1997, 36, 1842-
synthesis of biologically interesting 6-substituted pyrimidines and 1844. (d) Semenov, A.; Spatz, J.; Möller, M.; Lehn, J.; Sell, B.;
4(3H)-pyrimidinones. Arkivoc., 2006, vii, 452-478. (d) Lagoja, I. Schubert, D.; Weidl, C.; Schubert, U. Controlled arrangement of
M. Pyrimidine as constituent of natural biologically active supramolecular metal coordination arrays on surfaces. Angew.
compounds. Chem. Biodivers., 2005, 2, 1-50. Chem. Int. Ed., 1999, 38, 2547-2550.
[2] (a) Yang, W.; Ruan, Z.; Wang, Y.; Van Kirk, K.; Ma, Z.; Arey, B. [10] (a) Dickinson, R. P.; Bell, A. S.; Hitchcock, C. A.; Narayanaswami,
J.; Cooper, C. B.; Seethala, R.; Feyen, J. H. M.; Dickson, J. K. S.; Ray, S. J.; Richardson, K.; Troke, P. F. Novel antifungal 2-aryl-
Discovery and structure-activity relationships of trisubstituted 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives with high activity
against Aspergillus fumigatus. Bioorg. Med. Chem. Lett., 1996, 6,
pyrimidines/pyridines as novel calcium-sensing receptor
2031-2036. (b) Brodfuehrer, P. R.; Chen, B.-C.; Sattelberg, T. R.;
antagonists. J. Med. Chem., 2009, 52, 1204-1208. (b) Xie, F.; Zhao,
Smith, P. R.; Reddy, J. P.; Stark, D. R.; Quinlan, S. L.; Reid, J. G.;
H.; Zhao, L.; Lou, L.; Hu, Y. Synthesis and biological evaluation of
Thottathil, J. K.; Wang, S. An efficient Fischer Indole synthesis of
novel 2,4,5-substituted pyrimidine derivatives for anticancer
Avitriptan, a potent 5-HT1D receptor agonist. J. Org. Chem., 1997,
activity. Bioorg. Med. Chem. Lett., 2009, 19, 275-278. (c)
62, 9192-9202.
Sirichaiwat, C.; Intaraudom, C.; Kamchonwongpaisan, S.;
[11] (a) Zhang, Y.-M.; Razler, T.; Jackson, P. F. Synthesis of
Vanichtanankul, J.; Thebtaranonth, Y.; Yuthavong, Y. Target pyrimido[4,5-b]indoles and benzo[4,5]furo[2,3-d]pyrimidines via
guided synthesis of 5-benzyl-2,4-diamonopyrimidines: their palladium-catalyzed intramolecular arylation. Tetrahedron Lett.,
antimalarial activities and binding affinities to wild type and 2002, 43, 8235-8239. (b) Olivera, R.; SanMartin, R.; Tellitu, I.;
mutant dihydrofolate reductases from Plasmodium falciparum. J. Domınguez, E. The amine exchange/biaryl coupling sequence: a
Med. Chem., 2004, 47, 345-354. (d) Kamchonwongpaisan, S.; direct entry to the phenanthro[9,10-d]heterocyclic framework.
Quarrell, R.; Charoensetakul, N.; Ponsinet, R.; Vilaivan, T.; Tetrahedron., 2002, 58, 3021-3037. (c) Rosso, V. W.; Lust, D. A.;
Vanichtanankul, J.; Tarnchompoo, B.; Sirawaraporn, W.; Lowe, Bernot, P. J.; Grosso, J. A.; Modi, S. P.; Rusowicz, A.; Sedergran,
G.; Yuthavong, Y. Inhibitors of multiple mutants of Plasmodium T. C.; Simpson, J. H.; Srivastava, S. K.; Humora, M. J.; Anderson,
Metal free Synthesis of 2,4,6-Trisubstituted Pyrimidines Letters in Organic Chemistry, 2015, Vol. 12, No. 7 457
Pisal, R.; Chaskar, A. O-iodoxybenzoic acid in water: optimized using 4-nitro and 4-fluorophenacyldimethylsulfonium bromides
green alternative for multicomponent one-pot synthesis of 2-amino- with aromatic aldehydes. J. Ind. Chem. Soc., 2007, 84, 299-302. (d)
3,5-dicarbonitrile-6-thiopyridines. J. Braz. Chem. Soc., 2012, 23, Kröhnke, F.; Schmidt, E.; Zecher, W. Neue pyrimidin-synthesen.
966-969. Chem. Ber., 1964, 97, 1163-1175. (e) Lee, S.; Lee, D. H.; Lee, H.;
[27] (a) Schomaker, J. M.; Delia, T. J. Arylation of halogenated Kim, K.; Jang, J.; Hong, S. K.; Shin, C.; Lee, H. Heterocyclic
pyrimidines via a Suzuki coupling reaction. J. Org. Chem., 2001, compound and organic electronic element containing same. PCT
66, 7125-7128. (b) Forrester, A. R.; Gill, M.; Thomson, R. H. Int. Appl., WO 2014/010824 A1(f) Kuzmina, O. M.; Steib, A. K.;
Iminyls. Part 3. Formation of triaryl-pyridines and -pyrimidines Markiewicz, J. T.; Flubacher, D.; Knochel, P. Ligand-accelerated
from aryl--arylvinyliminyls. J. Chem. Soc. Perkin Trans. 1, 1979, iron- and cobalt-catalyzed cross-coupling reactions between N-
616-620. (c) Gupta, M. K.; Gupta, A. K.; Gupta, V.; Gupta, K. C. heteroaryl halides and aryl magnesium reagents. Angew. Chem. Int.
Synthesis of some new 2,4,6-trisubstituted phenyl pyrimidines Ed., 2013, 52, 4945-4949.